Medipharm Historical Balance Sheet

LABS Stock

CAD 0.07 0.01 8.33%

Trend analysis of Medipharm Labs Corp balance sheet accounts such as Total Current Liabilities of 13.7 M provides information on Medipharm Labs' total assets, liabilities, and equity, which is the actual value of Medipharm Labs Corp to its prevalent stockholders. By breaking down trends over time using Medipharm Labs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Medipharm Labs Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medipharm Labs Corp is a good buy for the upcoming year.

Medipharm Labs Inventory

14.89 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medipharm Labs Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Medipharm Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Medipharm Labs Corp at a specified time, usually calculated after every quarter, six months, or one year. Medipharm Labs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Medipharm Labs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Medipharm currently owns. An asset can also be divided into two categories, current and non-current.

Medipharm Labs Balance Sheet Chart

At this time, Medipharm Labs' Accumulated Other Comprehensive Income is very stable compared to the past year. As of the 5th of January 2025, Short Term Debt is likely to grow to about 2.7 M, while Short and Long Term Debt Total is likely to drop about 2.5 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Common Stock Inventory

Add Fundamental

Total Assets

Total assets refers to the total amount of Medipharm Labs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Medipharm Labs Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Medipharm Labs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Medipharm Labs Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Medipharm Labs' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Medipharm Labs Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medipharm Labs Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	632K	2.3M	2.6M	2.5M
Total Assets	65.5M	63.9M	73.5M	75.9M

Short Long Term Debt Total Total Assets

Medipharm Labs balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant And Equipment Net	Non Current Assets Total	Other Assets	Common Stock Total Equity	Short Term Investments	Other Current Assets	Net Invested Capital	Cash And Equivalents	Net Working Capital
Total Assets		0.71	0.91	0.95	0.99	0.95	-0.75	-0.51	0.81	0.94	0.94	0.6	0.73	0.92	1.0	0.53	0.75	0.98	0.98	0.93	0.82	0.74	0.76	1.0	0.93	0.98
Short Long Term Debt Total	0.71		0.73	0.84	0.63	0.54	-0.1	-0.07	0.65	0.47	0.47	0.14	0.56	0.92	0.71	0.84	0.32	0.69	0.7	0.73	0.41	0.77	0.58	0.68	0.43	0.65
Other Current Liab	0.91	0.73		0.87	0.89	0.92	-0.61	-0.66	0.56	0.84	0.84	0.71	0.55	0.87	0.88	0.6	0.85	0.96	0.95	0.74	0.9	0.78	0.92	0.91	0.87	0.86
Total Current Liabilities	0.95	0.84	0.87		0.91	0.86	-0.55	-0.39	0.85	0.81	0.81	0.52	0.62	0.98	0.94	0.73	0.63	0.93	0.95	0.95	0.71	0.7	0.66	0.94	0.8	0.89
Total Stockholder Equity	0.99	0.63	0.89	0.91		0.97	-0.83	-0.55	0.78	0.97	0.97	0.64	0.73	0.86	0.99	0.44	0.79	0.97	0.97	0.91	0.85	0.7	0.75	0.99	0.96	0.99
Net Tangible Assets	0.95	0.54	0.92	0.86	0.97		-0.84	-0.7	0.69	0.96	0.96	0.76	0.58	0.78	0.93	0.41	0.9	0.96	0.96	0.83	0.91	0.64	0.79	0.95	0.98	0.92
Net Debt	-0.75	-0.1	-0.61	-0.55	-0.83	-0.84		0.66	-0.52	-0.92	-0.92	-0.68	-0.6	-0.44	-0.76	0.02	-0.8	-0.74	-0.72	-0.63	-0.78	-0.44	-0.57	-0.78	-0.91	-0.8
Retained Earnings	-0.51	-0.07	-0.66	-0.39	-0.55	-0.7	0.66		-0.01	-0.65	-0.65	-0.95	-0.1	-0.3	-0.46	-0.24	-0.91	-0.62	-0.58	-0.24	-0.89	-0.41	-0.76	-0.54	-0.73	-0.49
Accounts Payable	0.81	0.65	0.56	0.85	0.78	0.69	-0.52	-0.01		0.69	0.69	0.16	0.62	0.8	0.82	0.42	0.33	0.71	0.75	0.96	0.37	0.41	0.25	0.78	0.63	0.78
Cash	0.94	0.47	0.84	0.81	0.97	0.96	-0.92	-0.65	0.69		1.0	0.7	0.71	0.74	0.94	0.31	0.85	0.93	0.92	0.83	0.88	0.67	0.74	0.95	0.99	0.96
Cash And Short Term Investments	0.94	0.47	0.84	0.81	0.97	0.96	-0.92	-0.65	0.69	1.0		0.7	0.71	0.74	0.94	0.32	0.85	0.93	0.92	0.83	0.88	0.67	0.74	0.95	0.99	0.96
Common Stock Shares Outstanding	0.6	0.14	0.71	0.52	0.64	0.76	-0.68	-0.95	0.16	0.7	0.7		0.12	0.41	0.56	0.3	0.9	0.72	0.7	0.38	0.92	0.35	0.73	0.64	0.79	0.57
Other Stockholder Equity	0.73	0.56	0.55	0.62	0.73	0.58	-0.6	-0.1	0.62	0.71	0.71	0.12		0.65	0.76	0.29	0.39	0.64	0.64	0.7	0.42	0.75	0.52	0.72	0.63	0.77
Total Liab	0.92	0.92	0.87	0.98	0.86	0.78	-0.44	-0.3	0.8	0.74	0.74	0.41	0.65		0.91	0.75	0.55	0.89	0.9	0.9	0.66	0.77	0.68	0.9	0.72	0.87
Total Current Assets	1.0	0.71	0.88	0.94	0.99	0.93	-0.76	-0.46	0.82	0.94	0.94	0.56	0.76	0.91		0.5	0.72	0.96	0.96	0.93	0.8	0.75	0.73	0.99	0.91	0.99
Short Term Debt	0.53	0.84	0.6	0.73	0.44	0.41	0.02	-0.24	0.42	0.31	0.32	0.3	0.29	0.75	0.5		0.34	0.57	0.57	0.55	0.38	0.61	0.49	0.5	0.32	0.41
Common Stock	0.75	0.32	0.85	0.63	0.79	0.9	-0.8	-0.91	0.33	0.85	0.85	0.9	0.39	0.55	0.72	0.34		0.83	0.81	0.54	0.95	0.6	0.86	0.77	0.9	0.72
Property Plant And Equipment Net	0.98	0.69	0.96	0.93	0.97	0.96	-0.74	-0.62	0.71	0.93	0.93	0.72	0.64	0.89	0.96	0.57	0.83		1.0	0.87	0.89	0.71	0.82	0.98	0.94	0.94
Non Current Assets Total	0.98	0.7	0.95	0.95	0.97	0.96	-0.72	-0.58	0.75	0.92	0.92	0.7	0.64	0.9	0.96	0.57	0.81	1.0		0.89	0.86	0.69	0.79	0.98	0.93	0.94
Other Assets	0.93	0.73	0.74	0.95	0.91	0.83	-0.63	-0.24	0.96	0.83	0.83	0.38	0.7	0.9	0.93	0.55	0.54	0.87	0.89		0.59	0.59	0.48	0.91	0.79	0.89
Common Stock Total Equity	0.82	0.41	0.9	0.71	0.85	0.91	-0.78	-0.89	0.37	0.88	0.88	0.92	0.42	0.66	0.8	0.38	0.95	0.89	0.86	0.59		0.65	0.9	0.85	0.92	0.82
Short Term Investments	0.74	0.77	0.78	0.7	0.7	0.64	-0.44	-0.41	0.41	0.67	0.67	0.35	0.75	0.77	0.75	0.61	0.6	0.71	0.69	0.59	0.65		0.82	0.73	0.62	0.74
Other Current Assets	0.76	0.58	0.92	0.66	0.75	0.79	-0.57	-0.76	0.25	0.74	0.74	0.73	0.52	0.68	0.73	0.49	0.86	0.82	0.79	0.48	0.9	0.82		0.76	0.78	0.73
Net Invested Capital	1.0	0.68	0.91	0.94	0.99	0.95	-0.78	-0.54	0.78	0.95	0.95	0.64	0.72	0.9	0.99	0.5	0.77	0.98	0.98	0.91	0.85	0.73	0.76		0.94	0.99
Cash And Equivalents	0.93	0.43	0.87	0.8	0.96	0.98	-0.91	-0.73	0.63	0.99	0.99	0.79	0.63	0.72	0.91	0.32	0.9	0.94	0.93	0.79	0.92	0.62	0.78	0.94		0.93
Net Working Capital	0.98	0.65	0.86	0.89	0.99	0.92	-0.8	-0.49	0.78	0.96	0.96	0.57	0.77	0.87	0.99	0.41	0.72	0.94	0.94	0.89	0.82	0.74	0.73	0.99	0.93

Click cells to compare fundamentals

Medipharm Labs Account Relationship Matchups

Medipharm Labs balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	118.2M	92.4M	65.5M	63.9M	73.5M	75.9M
Short Long Term Debt Total	18.5M	216K	632K	2.3M	2.6M	2.5M
Other Current Liab	10.0M	4.5M	4.0M	6.4M	7.4M	4.6M
Total Current Liabilities	24.2M	8.9M	9.5M	10.9M	12.5M	13.7M
Total Stockholder Equity	78.4M	83.1M	56.0M	53.0M	61.0M	59.2M
Net Tangible Assets	27.6M	131.5M	78.2M	83.1M	95.6M	59.3M
Net Debt	(1.5M)	(33.9M)	(23.5M)	(15.7M)	(14.1M)	(14.8M)
Retained Earnings	(74.5M)	(129.3M)	(163.6M)	(176.7M)	(159.1M)	(151.1M)
Accounts Payable	5.5M	3.0M	3.5M	2.1M	1.9M	1.8M
Cash	19.9M	34.1M	24.1M	18.0M	20.7M	19.7M
Cash And Short Term Investments	19.9M	34.1M	24.1M	18.0M	20.7M	19.7M
Common Stock Shares Outstanding	138.5M	249.9M	276.9M	363.3M	417.8M	438.7M
Liabilities And Stockholders Equity	118.2M	92.4M	65.5M	63.9M	73.5M	75.9M
Total Liab	39.8M	9.2M	9.5M	10.9M	12.6M	17.1M
Total Current Assets	81.5M	65.5M	47.3M	36.6M	42.1M	52.0M
Accumulated Other Comprehensive Income	14.4M	21.9M	28.4M	29.5M	33.9M	35.6M
Short Term Debt	7.7M	113K	598K	2.2M	2.6M	2.7M
Common Stock	138.5M	190.6M	191.3M	200.2M	230.3M	120.7M
Property Plant And Equipment Net	34.2M	25.9M	18.1M	25.3M	29.1M	25.4M
Non Current Assets Total	36.7M	26.8M	18.2M	27.3M	31.4M	27.7M
Non Currrent Assets Other	(52K)	876K	(18.2M)	1000.0K	900.0K	945.0K
Other Assets	2.1M	876K	0.0	1.0	0.9	0.86
Short Term Investments	2.1M	1.1M	756K	265K	304.8K	289.5K
Long Term Debt Total	8.8M	10.8M	103K	34K	39.1K	37.1K
Non Current Liabilities Total	15.6M	338K	34K	69K	62.1K	59.0K
Other Current Assets	4.6M	3.1M	2.3M	2.9M	3.3M	2.5M
Net Invested Capital	96.3M	83.1M	56.5M	55.1M	63.4M	73.3M
Cash And Equivalents	38.6M	19.9M	34.1M	24.1M	27.8M	22.9M
Net Working Capital	57.3M	56.7M	37.9M	25.8M	29.6M	44.1M
Property Plant Equipment	42.2M	34.1M	25.9M	18.1M	20.8M	25.0M
Net Receivables	34.9M	17.4M	13.2M	5.9M	5.3M	5.0M
Inventory	22.1M	11.0M	7.8M	9.9M	8.9M	14.9M
Property Plant And Equipment Gross	34.1M	51.3M	43.2M	52.3M	60.1M	43.5M
Short Long Term Debt	1.5M	7.4M	523K	2.1M	1.9M	2.8M
Capital Stock	138.5M	190.6M	191.3M	200.2M	230.3M	154.7M
Capital Lease Obligations	541K	216K	109K	190K	171K	329.8K

Pair Trading with Medipharm Labs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medipharm Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will appreciate offsetting losses from the drop in the long position's value.

Moving against Medipharm Stock

0.61	WMT	Walmart Inc CDR	Pair Corr
0.59	AMZN	Amazon CDR	Pair Corr
0.58	GOOG	Alphabet CDR	Pair Corr
0.57	AAPL	Apple Inc CDR	Pair Corr
0.48	COST	Costco Wholesale Corp	Pair Corr

The ability to find closely correlated positions to Medipharm Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medipharm Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medipharm Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medipharm Labs Corp to buy it.

The correlation of Medipharm Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medipharm Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medipharm Labs Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Medipharm Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Medipharm Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medipharm Historical Balance Sheet

Medipharm Labs Inventory

14.89 Million

About Medipharm Balance Sheet Analysis

Medipharm Labs Balance Sheet Chart

Total Assets

Total Current Liabilities

Medipharm Labs balance sheet Correlations

Medipharm Labs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medipharm Labs balance sheet Accounts

Pair Trading with Medipharm Labs

Moving against Medipharm Stock

Other Information on Investing in Medipharm Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity

Common Stock Shares Outstanding	- 0.95	Retained Earnings
Cash And Short Term Investments	- 0.92	Net Debt
Cash	- 0.92	Net Debt
Common Stock	- 0.91	Retained Earnings
Cash And Equivalents	- 0.91	Net Debt
Common Stock Total Equity	- 0.89	Retained Earnings